Sotera Health's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Sotera Health's ROA in the third quarter of 2026?
Sotera Health Company achieved a return on average assets (ROA) of 5.24 % in its third quarter of 2026, this is above SHC's average return on assets of 0.55%.
Sotera Health Companys assets during the 12 months ending in the third quarter of 2026 are valued at $3 billion

ROA has improved compared to 5.04% in the second quarter of 2026, due to net income growth.

However, within the Healthcare sector 147 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2026 quarter, so far to 1462, from total ROA ranking in the second quarter of 2026 at 2016.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Total Assets Change	8.09 %	4.6 %	5.41 %	7.23 %	1.09 %
Y / Y Net Income Change	20.64 %	573.74 %	-	182.78 %	184.74 %
Net Income (TTM) in million	173	163	118	78	55
Return On Assets (TTM)	5.24 %	5.04 %	3.67 %	2.46 %	1.78 %
SHC's Total Ranking	# 1462	# 2016	# 1911	# 2297	# 2283
Total Assets (TTM) in million	3,407	3,329	3,236	3,263	3,152
Seq. Total Assets Change	2.35 %	2.86 %	-0.84 %	3.53 %	-0.95 %
Seq. Net Income Change	8.85 %	101.75 %	-23.7 %	-28 %	507.89 %

SHC's 5 Years Annual ROA >> Back to SHC Management Effectiveness >> Compare SHC ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 19
Sector	# 148
Overall	# 1120

Return On Assets Statistics
High	Average	Low
5.26 %	0.55 %	-9.71 %
(Sep 30 2026)		(Sep 30 2023)

Financial Statements
Sotera Health's Assets	$ 3,407 million	SHC's Balance sheet
Sotera Health's Income	$ 58 million	Quarterly SHC's Income Statement
SHC's Income by Division		See SHC's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	7.23 %	-1.93 %	0.47 %	12.39 %	-
Total Assets in million	3,263	3,043	3,103	3,089	2,748
Y / Y Net Income Change	75.57 %	-13.58 %	-	-	-
Net Income in million	78	44	51	-234	117
Annual Return On Assets	2.39 %	1.46 %	1.66 %	-7.56 %	4.26 %

SHC's 5 Years Annual ROA >> Back to SHC Management Effectiveness >> Compare SHC ROA to its Competitors

Comment on SHC's ROA in the fiscal year ending 2025

In the fiscal year 2025 ROA improved to 2.39 % compared to prior year, due to annual net income growth of 75.57 % to $77.95 million, while value of Sotera Health's overall assets grew just by 7.23 % to $3,263.19 million, compared to $3,263.19 a year before.

More Return On Assets Ratios
SHC's' Return on Assets at Yahoo Finance
Healthcare Facilities Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
SHC's Roa Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for SHC's Competitors
Subscribers only: Roa for Sotera Health's Suppliers
Subscribers only: Return On Assets for SHC's Customers

You may also want to know
SHC's Roi	SHC's Inventory Turnover Ratio	SHC's Growth Rates	SHC's Dividend Comparisons
	SHC's Profitability Ratios	SHC's Asset Turnover Ratio	SHC's Dividend Growth
SHC's Roe	SHC's Valuation Ratios	SHC's Financial Strength Ratios	SHC's Dividend Payout Ratio

Companies with similar Return On Assets at Sep 30 2026, within Healthcare Sector	ROA
Vertex Pharmaceuticals Inc	14.16 %
Neurocrine Biosciences Inc	13.69 %
Illumina Inc	13.43 %
Healthcare Services Group Inc	12.79 %
Kiniksa Pharmaceuticals International Plc	12.64 %
Tenet Healthcare Corp	12.39 %
Hca Healthcare Inc	11.73 %
Carlisle Companies Incorporated	11.72 %
Regeneron Pharmaceuticals Inc	11.50 %
Lantheus Holdings Inc	11.43 %
Msa Safety Inc	11.01 %
Encompass Health Corporation	10.99 %
Inspire Medical Systems inc	10.89 %
Transmedics Group Inc	10.67 %
Bristol myers Squibb Company	10.47 %
Lemaitre Vascular Inc	10.28 %
Bio rad Laboratories Inc	9.88 %
3m Company	9.60 %
Bioventus Inc	9.47 %
Medinotec Inc	8.67 %
Tactile Systems Technology Inc	8.53 %
Penumbra Inc	8.13 %
Johnson and Johnson	8.06 %
Pacific Health Care Organization Inc	7.83 %
Boston Scientific Corporation	7.82 %
Ani Pharmaceuticals Inc	7.77 %
Stryker Corp	7.66 %
Abbvie Inc	7.48 %
Ensign Group Inc	7.00 %
Pediatrix Medical Group Inc	6.99 %

Date modified: 2026-11-06T13:04:38+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.